Development and implementation of a high-throughput compound screening assay for targeting disrupted ER calcium homeostasis in Alzheimer's disease.
Disrupted intracellular calcium homeostasis is believed to occur early in the cascade of events leading to Alzheimer's disease (AD) pathology. Particularly familial AD mutations linked to Presenilins result in exaggerated agonist-evoked calcium release from endoplasmic reticulum (ER). Here we r...
Main Authors: | Kamran Honarnejad, Alexander Daschner, Armin Giese, Andrea Zall, Boris Schmidt, Aleksandra Szybinska, Jacek Kuznicki, Jochen Herms |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3829862?pdf=render |
Similar Items
-
Discovery and characterization of novel drugs for Treatment of Alzheimer disease from a high-throughput compound screen
by: Honarnejad, Kamran
Published: (2014) -
The acute neurotoxicity of mefloquine may be mediated through a disruption of calcium homeostasis and ER function <it>in vitro</it>
by: Vahey Maryanne, et al.
Published: (2003-06-01) -
Membrane Incorporation, Channel Formation, and Disruption of Calcium Homeostasis by Alzheimer's β-Amyloid Protein
by: Masahiro Kawahara, et al.
Published: (2011-01-01) -
ER-Phagy: A New Regulator of ER Homeostasis
by: Ming Yang, et al.
Published: (2021-07-01) -
ER-Phagy and Its Role in ER Homeostasis in Plants
by: Yan Bao, et al.
Published: (2020-12-01)